Rituximab in the treatment of antisynthetase syndrome
Authors:
- 1 July 2006
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (7) , 974-975
Abstract
A 57 year old white woman had a 2 month history of painful synovitis of both hands, typical lesions of mechanic’s hands, and moderate proximal muscle weakness. Her laboratory evaluation showed a raised erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and muscle enzymes. Electromyography findings were consistent with the diagnosis of inflammatory myopathy. Prednisone 30 mg/day was immediately started with a good response and then progressively tapered to 10 mg/day.Keywords
This publication has 6 references indexed in Scilit:
- Rituximab in the treatment of dermatomyositis: An open‐label pilot studyArthritis & Rheumatism, 2005
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritisArthritis & Rheumatism, 2003
- Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatmentSeminars in Arthritis and Rheumatism, 2003
- Pulmonary involvement in polymyositis and in dermatomyositis.1998
- Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase EnzymesQJM: An International Journal of Medicine, 1990